Corcept sees 40% growth in 2025 revenue with promising trials, expanded patient base, and strong projections. Read my ...

Orforglipron, a daily GLP-1 receptor agonist pill, lowered HbA1c by up to 1.6% and body weight by 7.9% in a phase III trial ...

The Food and Drug Administration (FDA) has approved Isturisa ® (osilodrostat) for the treatment of endogenous hypercortisolemia in adults with Cushing syndrome for whom surgery is not an option or has ...

Osilodrostat, an oral cortisol synthesis inhibitor, was previously approved for treating adults with Cushing disease, a subtype of Cushing syndrome in which the hypercortisolemia is due to pituitary ...

Clinicians who are unaware of the pseudocondition may mistake elevated cortisol results for signs of true Cushing syndrome ...

WAPAKONETA, OH, UNITED STATES, April 11, 2025 /EINPresswire.com/ -- Rare diseases, especially Cushing’s, are often overlooked despite their profound impact on ...

Cushing’s syndrome survivor and public health advocate, Ms. Aisha Adamu Fari, has urged the Federal Government to prioritize research, awareness, and early diagnosis of rare diseases in Nigeria.

The focus on prevention represents a significant shift towards attacking Alzheimer’s disease earlier in its progression, rather than at the treatment stage. Those with Down syndrome are born ...

WAPAKONETA, OH, UNITED STATES, April 8, 2025 /EINPresswire.com/ -- No parent would ever wish to see their child suffer from an unknown disease with no cure in the ...

In his tear-jerking memoir, Surviving Cushing's Disease: A Young Man's Journey, Chuck Knueve recounts the gritty, emotional story of his son's battle to be diagnosed with Cushing's disease ...